Updated September 20, 2021
Notice ID: 75N95021Q00401
“This requirement is, on a brand-name-or-equal basis, to provide renewal enterprise licenses for the installed base of HALO digital pathology software tools (i.e. “brand-name”), or to obtain enterprise-level digital pathology software tools that constitute a platform fully equal in form, fit, and function to the HALO products (i.e. “or equal”) listed in the attached combined synopsis/solicitation…”
Updated August 30, 2021
Notice ID: 75N95021Q00401
“Background: HALO digital pathology software provides a platform for specialized analysis and management of digital histology images. HALO is a product of Indica Labs. The platform is hosted by NCATS and made available to multiple users of the NCATS Secure Scientific Platforms Environment (the “Environment”), an NCATS-hosted platform for collaboration across NIH institutes and centers, other Government agencies, and external collaborators. HALO receives particularly intensive use by users from the National Cancer Institute (NCI), NCATS, and the National COVID Cohort Collaborative (N3C).”
“Project requirements: This requirement is, on a brand-name-or-equal basis, to renew enterprise licenses for the installed base of HALO digital pathology software tools (i.e. “brand-name”), or to obtain enterprise-level digital pathology software tools that constitute a platform fully equal in form, fit, and function to the following HALO products (i.e. “or equal”) …”
Posted July 29, 2021
Notice ID 75N95021Q00317
“The National Institute on Drug Abuse (NIDA), NIDA Office of Acquisition – NCATS Section, on behalf of the National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to:
Indica Labs, Inc…” “for renewal of enterprise licenses for HALO digital pathology software…”
“This acquisition is conducted as non-competitive under the authority of 41 U.S.C. 3304(a)(1) and FAR 6.302-1, Only one responsible source ad no other supplies or services will satisfy agency requirements…”
“DESCRIPTION OF REQUIREMENT
Purchase Description
HALO Digital Pathology Enterprise Software License Renewal
Purpose and Objectives
This requirement is to renew enterprise licenses for the installed base of HALO digital pathology software tools. This software provides for specialized analysis and management of digital pathology images.
The HALO platform is hosted by NCATS and made available to multiple users of the NCATS Secure Scientific Platforms Environment (the “Environment”), an NCATS-hosted platform for collaboration across NIH institutes and centers, other Government agencies, and external collaborators. HALO receives particularly intensive use by users from the National Cancer Institute (NCI), NCATS, and the National COVID Cohort Collaborative (N3C).
The acquisition consists of renewal of the enterprise licenses for the following commercial items:
- Licenses
- Product Number
- HALO Unlimited Image Analysis Platform floating term seat license PRO986
- HALO AI Add-On floating seat term license, #PRO987
- HALO Link 1000 user license, #PRO921
- HALO Algorithm Development SDK annual, #PRO751
- HALO Analysis Cluster – Annual License, #PRO 575
- HALO AP assay-drive anatomical pathology case management and slide quantification platform, 25,000 slides, #PRO743
- Custom software development (NCI anonymization feature), #PRO710
The salient characteristic of this requirement is the vendor’s ability to provide renewal of the enterprise-wide license for this software.
HALO software is licensed exclusively through Indica Labs, Inc., and is not sold through resellers.
Period of Performance
The license period is 9/15/2021 – 6/30/2022.
The award is expected to include two one-year option periods.
Option Period One (1): 7/01/2022-6/30/2023
Option period Two (2): 7/01/2023-6/30/2024…”
